Specifically, PD1 blockade promoted an increase in CD8+ Teff (PD1loTOXlo) cells and an approximately threefold decrease in the frequency of CD8+ Tex (TOX+PD1+) cells within tumours compared to DR treatment alone (Fig. 7c). This evidence concerns the gene CD8A and neoplasm.